MedImmune FluMist review
Executive Summary
Dec. 17 meeting of FDA's Vaccines & Related Biological Products Advisory Committee on MedImmune's FluMist intranasal vaccine for prevention of influenza will be held at the Marriott in Bethesda, Md., at 8:30 a.m. The committee is expected to focus on safety in children under five (1"The Pink Sheet" Nov. 4, p. 13)...